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Furthermore, Mastorakos et al.6 reported
that plasma antidiuretic hormone levels
were elevated after IL-6 injection in
cancer patients, suggesting that IL-6
activated the magnocellular ADH-
secreting neurons and that it might be
involved in SIADH. Activation of the
subfornical organ and the organum
vasculosum of the lamina terminalis by
IL-6 could eventually lead to thirst and
increased vasopressin secretion by
neurons from the supraoptic nucleus and
paraventricular nucleus.4 The
combination of antidiuresis and increased
water intake may result in hyponatremia.
Therefore, there is a possibility that
IL-6 may play a central role in the
pathogenesis of hyponatremia
associated with GBS. However, further
studies are necessary to elucidate if IL-
6 crosses the blood-brain barrier
(BBB), or whether lipopolysaccharides
cross the BBB and then increase IL-6
locally in the brain in the future.
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To the Editor,
It was with great interest that we read
the article by Quiñones et al1 in which
they mention how toxicity secondary
to starting new treatments in patients
with renal failure can give rise to false
diagnoses.
One of the patients cited by the authors
suffered from neurotoxicity due to
acyclovir. Acyclovir and its ester,
valacyclovir, are widely used in treating
infection with the varicella zoster virus,
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To the Editor,
We read with great interest the
contribution by Monzón et al.1 They
reported a significant case of a man who
had Guillain-Barré syndrome (GBS) with
syndrome of inappropriate antidiuretic
hormone (SIADH) and speculated that
increased sensitivity to vasopressin in the
renal tubule and a long-lasting hypo-
osmolarity or antidiuretic substances
might cause GBS-related SIADH.
However, we would like to add a possible
pathomechanism in the development of
hyponatremia associated with GBS.
According to a previous study by
Maimone et al.,2 interleukin (IL)-6, a
multifunctional cytokine, might be
implicated in the immunopathogenesis
of GBS. In their study, serum IL-6
levels were increased in six (26%) of
23 GBS patients, and detectable levels
of IL-6 were also found in the
cerebrospinal fluid in 13 (57%).2
Using enzyme-linked immunospot
assays, Press et al.3 found elevated
numbers of IL-6-secreting blood
mononuclear cells during the acute
phase in patients with GBS.
Quite recently and importantly, Swart
et al.4 depicted the cascade-like fashion
of events initiated by an inflammatory
stimulus (lipopolysaccharides), with
tumor necrosis factor-α secreted first,
IL-1β second, and IL-6 last, suggesting
possible pathways connecting IL-6 to
vasopressin release. These pro-
inflammatory cytokines are secreted
into the systemic circulation to initiate
the acute phase response which is
involved in the innate immune system.5
A) COMMENTS ON PUBLISHED ARTICLES
